The true cost differential between mifepristone and misoprostol and misoprostol-alone regimens for medical abortion

Contraception

Volumn 71, Issue 1, 2005, Pages 26-30

  Creinin, Mitchell D ^a   Shore, Eliane ^b   Balasubramanian, Shyamala ^c   Harwood, Bryna ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

Cost; Medical abortion; Mifepristone; Misoprostol

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DEVELOPING COUNTRY; DRUG COST; DRUG EFFICACY; HUMAN; THERAPEUTIC ABORTION;

EID: 27744572650     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2004.07.011     Document Type: Article

References (16)

1. Bygdeman M, Danielsson KG. Options for early therapeutic abortion: a comparative review. Drugs 2002;62:2459-70.
2. Wiebe E, Dunn S, Guilbert E, Jacot F, Lugtig L. Comparison of abortions induced by methotrexate or mifepristone followed by misoprostol. Obstet Gynecol 2002;99:813-9.
3. Jain JK, Dutton C, Harwood B, Meckstroth KR, Mishell Jr DR. A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy. Hum Reprod 2002;17:1477-82.
4. Blanchard K, Winikoff B, Ellertson C. Misoprostol used alone for the termination of early pregnancy. A review of the evidence. Contraception 1999;59:209-17.
5. Goldberg AB, Greenberg MB, Darney PD. Misoprostol and pregnancy. N Engl J Med 2001;344:38-47.
6. World Health Organization. Methotrexate for the termination of early pregnancy. A review of its toxicology. Geneva (Switzerland): World Health Organization; 1997 [April 18].
7. Creinin MD, Potter C, Holovanisin M, Janczukiewicz L, Pymar HC, Schwartz JL, et al. Mifepristone and misoprostol and methotrexate and misoprostol in clinical practice for abortion. Am J Obstet Gynecol 2003;187:64-9.
8. Schaff EA, Fielding SL, Westhoff C, Ellertson C, Eisinger SH, Stadalius LS, et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion. A randomized trial. JAMA 2000;284:1948-53.
9. Schaff EA, Fielding SL, Westhoff C. Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion. Contraception 2001;64:81-5.
10. Harwood BJ. Life table analysis to estimate the efficacy of misoprostol in the USC medical abortion trials. Ann Arbor (MI): UMI Dissertation Services; 2001.
11. Jain JK, Meckstroth KR, Mishell Jr DR. Early pregnancy termination with intravaginally administered sodium chloride solution-moistened misoprostol tablets: historical comparison with mifepristone and oral misoprostol. Am J Obstet Gynecol 1999;181: 1386-91.
12. Jain JK, Meckstroth KR, Park M, Mishell Jr DR. A comparison of tamoxifen and misoprostol to misoprostol alone for early pregnancy termination. Contraception 2000;60:353-6.
13. Jain JK, Harwood B, Meckstroth KR, Mishell Jr DR. Early pregnancy termination with vaginal misoprostol combined with loperamide and acetaminophen prophylaxis. Contraception 2001;63: 217-21.
14. Nissen D. Mosby's drug consult, 13th ed. St. Louis (MO): Mosby-Year Book; 2003.
15. US Department of Labor. Bureau of Labor Statistics. 2001 National occupational employment and wages estimates [accessed at http://www.bls.gov/oes/ 2001/oes-00al.htm].
16. Wiebe ER, Janssen P. Time lost from work among women choosing medical or surgical abortions. Women's Health Issues 2000;10:327-32.